Skip to main content
NIH Intramural Research Program, Our Research Changes Lives

Navigation controls

  • Search
  • Menu

Social follow links

  • Podcast
  • Instagram
  • Twitter
  • YouTube
  • LinkedIn

Main navigation

  • About Us
    • What Is the IRP?
    • History
    • Honors
      • Nobel Prize
      • Lasker Award
      • Breakthrough Prize
      • Shaw Prize
      • Presidential Early Career Award for Scientists and Engineers (PECASE)
      • Presidential Medal of Freedom
      • National Medal of Science
      • Searle Scholars
      • The National Academy of Sciences
      • The National Academy of Medicine
      • The National Academy of Engineering
      • The American Academy of Arts and Sciences
      • National Medal of Technology & Innovation
      • Samuel J. Heyman Service to America Medals
      • Crafoord Prize
      • Fellows of the Royal Society
      • Canada Gairdner Awards
    • Organization & Leadership
    • Our Programs
      • NCI
      • NEI
      • NHGRI
      • NHLBI
      • NIA
      • NIAAA
      • NIAID
      • NIAMS
      • NIBIB
      • NICHD
      • NIDA
      • NIDCD
      • NIDCR
      • NIDDK
      • NIEHS
      • NIMH
      • NIMHD
      • NINDS
      • NINR
      • NLM
      • CC
      • NCATS
      • NCCIH
    • Research Campus Locations
    • Contact Information
  • Our Research
    • Scientific Focus Areas
      • Biomedical Engineering & Biophysics
      • Cancer Biology
      • Cell Biology
      • Chemical Biology
      • Chromosome Biology
      • Clinical Research
      • Computational Biology
      • Developmental Biology
      • Epidemiology
      • Genetics & Genomics
      • Health Disparities
      • Immunology
      • Microbiology & Infectious Diseases
      • Molecular Biology & Biochemistry
      • Molecular Pharmacology
      • Neuroscience
      • RNA Biology
      • Social & Behavioral Sciences
      • Stem Cell Biology
      • Structural Biology
      • Systems Biology
      • Virology
    • Principal Investigators
      • View by Investigator Name
      • View by Scientific Focus Area
    • Accomplishments
      • View All Accomplishments by Date
      • View All Health Topics
      • The Body
      • Health & Wellness
      • Conditions & Diseases
      • Procedures
    • Accelerating Science
      • Investing in Cutting-Edge Animal Models
      • Creating Cell-Based Therapies
      • Advancing Computational and Structural Biology
      • Combating Drug Resistance
      • Developing Novel Imaging Techniques
      • Charting the Pathways of Inflammation
      • Zooming in on the Microbiome
      • Uncovering New Opportunities for Natural Products
      • Stimulating Neuroscience Research
      • Pursuing Precision Medicine
      • Unlocking the Potential of RNA Biology and Therapeutics
      • Producing Novel Vaccines
    • Research in Action
      • View All Stories
      • Battling Blood-Sucking Bugs
      • Unexpected Leads to Curb Addiction
      • Shaping Therapies for Sickle Cell Disease
      • The Mind’s Map Maker
    • Trans-IRP Research Resources
      • Supercomputing
    • IRP Review Process
    • Commercializing Inventions
  • NIH Clinical Center
    • Clinical Center Facilities
    • Clinical Faculty
    • Advancing Translational Science
    • Clinical Trials
      • Get Involved with Clinical Research
      • Physician Resources
  • News & Events
    • In the News
    • I am Intramural Blog
    • Speaking of Science Podcast
    • SciBites Video Shorts
    • The NIH Catalyst Newsletter
    • Events
  • Careers
    • Faculty-Level Scientific Careers
    • Trans-NIH Scientific Recruitments
      • Stadtman Tenure-Track Investigators
        • Science, the Stadtman Way
      • Lasker Clinical Research Scholars
      • Independent Research Scholar
    • Scientific & Clinical Careers
    • Administrative Careers
  • Research Training
    • Program Information
    • Training Opportunities
    • NIH Work/Life Resources
The NIH Catalyst: A Publication About NIH Intramural Research

National Institutes of Health • Office of the Director | Volume 23 Issue 3 • May–June 2015

From the Deputy Director for Intramural Research

Making Cancer History

BY MICHAEL GOTTESMAN, DDIR

From the Deputy Director for Intramural Research

Those of you who tuned into the six-hour PBS documentary Cancer: The Emperor of All Maladies—a Ken Burns production based on a Pulitzer prize–winning book by Siddhartha Mukherjee—may have noticed how closely the history of cancer advances parallels the history of the NIH intramural research program. From combination chemotherapy for lymphoma and leukemia, through the discovery of virus vectors and the development of vaccines, to immunotherapy and the promise of personalized medicine, that was us making cancer history.

I was in college and medical school at Harvard in the 1960s when I started hearing about all the amazing work being done at the National Cancer Institute (NCI) and the Clinical Center. Imagine the stark reality back then: Nearly every child with leukemia died of that disease; the survival rate was essentially zero percent.

The pioneering work of NCI’s Emil Frei and Emil Freireich and their four-drug approach placed us on the road to a 90 percent survival rate. The “two Emils”—with the same first name and neighboring labs on the 12th floor of Building 10, but utterly different personalities—were both featured in the Ken Burns documentary, as was NCI Clinical Director C. Gordon Zubrod, who was NCI scientific director during this time. All three ultimately won Lasker awards for their chemotherapy work.

Other NIH heroes—and Lasker winners—of this era include Paul Carbone and Vincent DeVita (combination therapy to treat Hodgkin disease); Roy Hertz and Min Chiu Li (treatment of gestational choriocarcinoma); James F. Holland (use of combination therapy to treat acute leukemia in children); and John L. Ziegler (increasing the cure rate for Burkitt’s tumor by chemotherapy.

If I could insert another episode into Ken Burns’ three-part series, it would include the NIH’s profound contributions to the basic science of cancer. During those heady clinical advances of the 1960s, NCI’s Michael Potter was studying plasmacytomas, antibodies, and the genetic factors leading to the susceptibility and resistance to tumor growth. He would win the Lasker Award in 1984. During the 1970s, NCI’s Robert Gallo was exploring retroviruses and their role in cancer; he’d win the Lasker for that work in 1982 (he also won in 1986 for determining that HIV caused AIDS).

Meanwhile, NCI’s Ira Pastan (who mentored Harold Varmus and Robert Lefkowitz) and Jesse Roth were pioneering the field of receptor biology. In the National Institute of Allergy and Infectious Diseases (NIAID), Anthony Fauci helped spearhead the concerted efforts to understand and control human immunodeficiency virus and its associated immunodeficiencies and cancers.

Decades of research by NCI’s Douglas Lowy and John Schiller paid off with the staggeringly successful vaccine against the human papillomavirus, the leading cause of cervical cancer (and a significant cause of many other cancers, too.) Among their high-profile awards for this achievement was the National Medal of Technology and Innovation in 2014 (http://1.usa.gov/1bvnZRY).

Similarly, Harvey Alter of the Clinical Center co-discovered the hepatitis B virus and laid the groundwork for the detection of the hepatitis C virus, both major causes of liver cancer. Alter won the Lasker in 2000 and the Gairdner award in 2013. In NIAID, Robert Purcell’s work on various strains of hepatitis also led to vaccine development and has reduced the incidence of liver cancer, particularly in China. Although vaccines were mentioned in the cancer documentary only in passing, the work of these NIH scientists will save countless lives. With all these Lasker awardees, it’s no wonder that the Clinical Center itself earned a Lasker, in 2011, for transforming scientific advances into innovative therapies and providing high-quality care to patients.

Palliative care has come a long way, too. Work by NCI’s Lori Wiener and the National Institute of Mental Health’s Maryland Pao on helping teenagers better face an early death was featured in the New York Times on Sunday, March 29, 2015 (http://nyti.ms/1H1Kzxn).

There’s much more to highlight, as you can imagine. I’d like to think my own research on cancer drug resistance has deepened our understanding of cancer…at least in terms of why it is so difficult to cure.

Cancer: The Emperor of All Maladies ended, as expected, on a message of hope, focusing on cancer immunotherapy, named the 2013 scientific breakthrough of the year by the journal Science (http://bit.ly/1QjLc9x). NCI’s Steve Rosenberg, featured heavily in the documentary, is one of the fathers of this field. His, too, has been a decades-long research journey quite possibly on the threshold of profound success.

It was fun to marvel at all of the NIH alumni featured in the Ken Burns documentary: David Nathan, Michael Bishop, Harold Varmus, Rick Klausner, and probably a few more luminaries who trained here in the 1960s and 1970s. But Senator Ben Cardin, in his address to the NIH staff on April 2, aptly noted that the true star of the documentary was NIH itself—that is, you, as members of the vast research enterprise (http://videocast.nih.gov/launch.asp?18925).

As Eric Lander of the Massachusetts Institute of Technology so skillfully summarized in the documentary, advances may seem slow at one level—cancer continues to be a major killer—but considering the complexity of cancer, it is mind-boggling how far the science and treatments have progressed in the last 50 years. I’m not so cynical to think, as some do, that the war on cancer has been lost. The battle rages on, and I dare say we are winning.


To view the PBS documentary Cancer: The Emperor of All Maladies, go to http://video.pbs.org/program/story-cancer-emperor-all-maladies/. To see the list of NIH’s Lasker winners, go to https://irp.nih.gov/about-us/honors/lasker-award.

This page was last updated on Monday, April 25, 2022

  • Issue Overview
  • Features
    • NIH Rare Disease Day
    • WHIM Syndrome
    • The Role of Environmental Exposures in Obesity
    • Crossroads of Medicine and the Media
    • Telomeres, Sex, and Hospital Infections
    • News from the National Eye Institute
    • Celebrating Marshall Nirenberg
    • NIH Expands the Medical Scholars Program
    • LASKER CLINICAL RESEARCH SCHOLARS
  • Departments
    • From the Deputy Director for Intramural Research
    • News You Can Use
    • Research Briefs
    • Colleagues: Recently Tenured
    • News Briefs
    • Laboratory Confessions
    • Announcements
    • Announcements-Kudos
  • Issue Contents
  • Download this issue as a PDF

Catalyst menu

  • Current Issue
  • Previous Issues
  • About The NIH Catalyst
  • Contact The NIH Catalyst
  • Share Your Story
  • NIH Abbreviations

Subscribe Today!

Subscribe to The NIH Catalyst Newsletter and receive email updates.

Subscribe

Get IRP Updates

Subscribe

  • Email
  • Print
  • Share Twitter Facebook LinkedIn

Main navigation

  • About Us
    • What Is the IRP?
    • History
    • Honors
    • Organization & Leadership
    • Our Programs
    • Research Campus Locations
    • Contact Information
  • Our Research
    • Scientific Focus Areas
    • Principal Investigators
    • Accomplishments
    • Accelerating Science
    • Research in Action
    • Trans-IRP Research Resources
    • IRP Review Process
    • Commercializing Inventions
  • NIH Clinical Center
    • Clinical Center Facilities
    • Clinical Faculty
    • Advancing Translational Science
    • Clinical Trials
  • News & Events
    • In the News
    • I am Intramural Blog
    • Speaking of Science Podcast
    • SciBites Video Shorts
    • The NIH Catalyst Newsletter
    • Events
  • Careers
    • Faculty-Level Scientific Careers
    • Trans-NIH Scientific Recruitments
    • Scientific & Clinical Careers
    • Administrative Careers
  • Research Training
    • Program Information
    • Training Opportunities
    • NIH Work/Life Resources
  • Department of Health and Human Services
  • National Institutes of Health
  • USA.gov

Footer

  • Home
  • Contact Us
  • IRP Brand Materials
  • HHS Vulnerability Disclosure
  • Web Policies & Notices
  • Site Map
  • Search